Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with higher rates of hemolysis have lower steady-state Hb levels and are more likely to develop vascular injury and organ dysfunction as they age, manifesting as pulmonary hypertension, diastolic left heart disease, and renal dysfunction (proteinuria, albuminuria, and chronic kidney dysfunction) (62, 64, 65, 70, 79).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [64]
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationQuiñones, M. A., Otto, C. M., Stoddard, M., Waggoner, A., & Zoghbi, W. A. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.120202 · Cited by 2,130
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Cited by
Items 301–400 of 999
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Klings, E. S., & Farber, H. W. (2004) · New England Journal of Medicine · doi:10.1056/nejm200406103502418 · Cited by 64
Gordeuk, V. R., Campbell, A., Rana, S., Nouraie, M., Niu, X., Minniti, C. P., Sable, C., Darbari, D., Dham, N., Onyekwere, O., et al. (2009) · Blood · doi:10.1182/blood-2009-04-218040 · Cited by 63
Self-citationSickle Cell Disease—Pathophysiology and Treatment
Redding‐Lallinger, R., & Knoll, C. M. (2006) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2006.07.002 · Cited by 73
Voskaridou, E., Tsetsos, G., Tsoutsias, A., Spyropoulou, E., Christoulas, D., & Terpos, E. (2007) · Haematologica · doi:10.3324/haematol.11136 · Cited by 63
Dubert, M., Élion, J., Tolo, A., Diallo, D. A., Diop, S., Diagne, I., Sanogo, I., Belinga, S., Guifo, O., Wamba, G., et al. (2017) · Blood · doi:10.1182/blood-2016-12-755777 · Cited by 73
Ataga, K. I., Brittain, J. E., Moore, D. F., Jones, S., Hulkower, B., Strayhorn, D., Adam, S. S., Redding‐Lallinger, R., Nachman, P. H., & Orringer, E. P. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01471.x · Cited by 71
Ataga, K. I., & Stocker, J. W. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802708011 · Cited by 62
Ristow, B., Ali, S., Ren, X., Whooley, M. A., & Schiller, N. B. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.108 · Cited by 62
Pulmonary hypertension in sickle cell disease children under 10 years of age
Colombatti, R., Maschietto, N., Varotto, E., Grison, A., Grazzina, N., Meneghello, L., Teso, S., Carli, M., Milanesi, O., & Sainati, L. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08269.x · Cited by 61
The WHO Classification of Pulmonary Hypertension: A Case‐Based Imaging Compendium
Ryan, J. J., Thenappan, T., Luo, N., Ha, T., Patel, A. R., Rich, S., & Archer, S. L. (2012) · Pulmonary Circulation · doi:10.4103/2045-8932.94843 · Cited by 76
Severe Nocturnal and Postexercise Hypoxia in Children and Adolescents with Sickle Cell Disease
Halphen, I., Elie, C., Brousse, V. A. M., Bourgeois, M. L., Allali, S., Bonnet, D., & de Montalembert, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097462 · Cited by 68
Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease
Pashankar, F. D., Carbonella, J., Bazzy‐Asaad, A., & Friedman, A. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07501.x · Cited by 62
Taylor, J. G., Ackah, D., Cobb, C., Orr, N., Percy, M. J., Sachdev, V., Machado, R., Castro, O., Kato, G. J., Chanock, S. J., et al. (2008) · American Journal of Hematology · doi:10.1002/ajh.21035 · Cited by 60
Self-citationPriapism in Sickle-Cell Disease: A Hematologist’s Perspective
Kato, G. J. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02287.x · Cited by 71
Minneci, P. C., Deans, K. J., Shiva, S., Zhi, H., Banks, S. M., Kern, S., Natanson, C., Solomon, S. B., & Gladwin, M. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00151.2008 · Cited by 60
Self-citationClinical differences between children and adults with pulmonary hypertension and sickle cell disease
Hagar, R. W., Michlitsch, J., Gardner, J. L., Vichinsky, E. P., & Morris, C. R. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06822.x · Cited by 65
Role of the Red Blood Cell in Nitric Oxide Homeostasis and Hypoxic Vasodilation
Gladwin, M. T. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-34817-9_17 · Cited by 59
Self-citationChaturvedi, S., Ghafuri, D. L., Jordan, N., Kassim, A. A., Rodeghier, M., & DeBaun, M. R. (2018) · American Journal of Hematology · doi:10.1002/ajh.25202 · Cited by 60
Management of sickle cell disease
de Montalembert, M. (2008) · BMJ · doi:10.1136/bmj.a1397 · Cited by 63
Management of Sickle Cell Disease in Pregnancy
Sharma, R. (2012) · Apollo Medicine · doi:10.1016/j.apme.2012.07.002 · Cited by 59
Driscoll, M. C. (2007) · Pediatrics in Review · doi:10.1542/pir.28-7-259 · Cited by 76
Dham, N., Ensing, G., Minniti, C., Campbell, A., Arteta, M., Rana, S., Darbari, D., Nouraie, M., Onyekwere, O., Lasota, M., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.034 · Cited by 58
Self-citationMedical management of ischemic stuttering priapism: a contemporary review of the literature
Bernie, H. L., Kutlu, Ö., & Bivalacqua, T. J. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2011.114 · Cited by 58
Redefining pulmonary hypertension
Maron, B. A., Brittain, E. L., Choudhary, G., & Gladwin, M. T. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30498-8 · Cited by 58
Self-citationSildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertension
Hemnes, A. R., & Champion, H. C. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.3.293 · Cited by 64
Sickle cell disease: time for a closer look at treatment options?
Sheth, S., Licursi, M., & Bhatia, M. (2013) · British Journal of Haematology · doi:10.1111/bjh.12413 · Cited by 57
Nébor, D., Broquère, C., Brudey, K., Mougenel, D., Tarer, V., Connes, P., Élion, J., & Romana, M. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.06.003 · Cited by 63
Landburg, P. P., Teerlink, T., Biemond, B. J., Brandjes, D. P. M., Muskiet, F. A. J., Duits, A. J., & Schnog, J. B. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.02.005 · Cited by 64
Brousseau, D. C., McCarver, D. G., Drendel, A. L., Divakaran, K., & Panepinto, J. A. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.01.049 · Cited by 59
The association between sickle cell disease and dental caries in African Americans
Laurence, B., George, D., Woods, D., Shosanya, A., Katz, R. V., Lanzkron, S., Diener‐West, M., & Powe, N. R. (2006) · Special Care in Dentistry · doi:10.1111/j.1754-4505.2006.tb01430.x · Cited by 59
Pavenski, K., Saidenberg, E., Lavoie, M., Tokessy, M., & Branch, D. R. (2011) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2011.07.003 · Cited by 60
Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats
Al Husseini, A., Bagnato, G., Farkas, L., Gomez-Arroyo, J., Farkas, D., Mizuno, S., Kraskauskas, D., Abbate, A., Van Tassel, B., Voelkel, N. F., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00196511 · Cited by 56
Mechanisms of Slower Nitric Oxide Uptake by Red Blood Cells and Other Hemoglobin-containing Vesicles
Azarov, I., Liu, C., Reynolds, H., Tsekouras, Z., Lee, J. S., Gladwin, M. T., & Kim‐Shapiro, D. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228650 · Cited by 58
Self-citationPrognostic significance of early vaso-occlusive complications in children with sickle cell anemia
Quinn, C. T., Shull, E. P., Ahmad, N., Lee, N. J., Rogers, Z. R., & Buchanan, G. R. (2006) · Blood · doi:10.1182/blood-2006-02-005082 · Cited by 56
Cardiovascular complications in patients with sickle cell disease
Gladwin, M. T. (2017) · Hematology · doi:10.1182/asheducation-2017.1.423 · Cited by 64
Self-citationLaboratory and echocardiography markers in sickle cell patients with leg ulcers
Minniti, C. P., Taylor, J. G., Hildesheim, M. E., Oneal, P. A., Wilson, J., Castro, O. L., Gordeuk, V. R., & Kato, G. J. (2011) · American Journal of Hematology · doi:10.1002/ajh.22065 · Cited by 62
Self-citationGhosh, S., Tan, F., & Ofori-Acquah, S. F. (2012) · Anemia · doi:10.1155/2012/582018 · Cited by 56
Pulmonary complications of sickle cell disease in children
Caboot, J. B., & Allen, J. L. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3282ff62c4 · Cited by 55
Schaer, C. A., Vallelian, F., Imhof, A., Schoedon, G., & Schaer, D. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0706453 · Cited by 55
Quinn, C. T., Smith, E. P., Arbabi, S., Khera, P. K., Lindsell, C. J., Niss, O., Joiner, C. H., Franco, R. S., & Cohen, R. M. (2016) · American Journal of Hematology · doi:10.1002/ajh.24562 · Cited by 55
Yalamanoglu, A., Deuel, J., Hunt, R., Baek, J. H., Hassell, K. L., Redinius, K., Irwin, D. C., Schaer, D. J., & Buehler, P. W. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00269.2018 · Cited by 60
Pathology of sickle cell disease
Malowany, J. I., & BUTANY, J. W. (2012) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2011.07.005 · Cited by 63
Alterations of the Arginine Metabolome in Sickle Cell Disease
Morris, C. R. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.008 · Cited by 59
Hematological disorders and pulmonary hypertension
Mathew, R., Huang, J. L., WU, J. M., Fallon, J. T., & Gewitz, M. H. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i12.703 · Cited by 58
Current Management of Sickle Cell Anemia
McGann, P. T., Nero, A. C., & Ware, R. E. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011817 · Cited by 63
Advances in the Management of Pediatric Pulmonary Hypertension
Oishi, P. E., Datar, S. A., & Fineman, J. R. (2011) · Respiratory Care · doi:10.4187/respcare.01297 · Cited by 56
Heart Failure in Haemoglobinopathies: Pathophysiology, Clinical Phenotypes, and Management
Farmakis, D. T., Triposkiadis, F. K., Lekakis, J. P., & Parissis, J. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.708 · Cited by 58
Ruhl, A. P., Sadreameli, S. C., Allen, J. L., Bennett, D. P., Campbell, A., Coates, T. D., Diallo, D. A., Field, J. J., Fiorino, E. K., Gladwin, M. T., et al. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201906-433st · Cited by 61
Self-citationLee, M. T., Small, T., Khan, M. A., Rosenzweig, E. B., Barst, R. J., & Brittenham, G. M. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07779.x · Cited by 52
Adams-Graves, P. E., & Bronté-Hall, L. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2016.1180242 · Cited by 58
Novelli, E. M., LITTLE-IHRIG, L. L., Knupp, H. E., Rogers, N. M., Yao, M., Baust, J., Meijles, D. N., Croix, C. M. S., Ross, M. A., Pagano, P. J., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00302.2018 · Cited by 51
Self-citationAtaga, K. I., Gordeuk, V. R., Agodoa, I., Colby, J. A., Gittings, K., & Allen, I. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229959 · Cited by 58
Kassim, A. A., de la Fuente, J., Nur, E., Wilkerson, K. L., Alahmari, A. D., Seber, A., Bonfim, C., Simões, B. P., Alzahrani, M., Eckrich, M. J., et al. (2024) · Blood · doi:10.1182/blood.2023023301 · Cited by 54
Hypoxemia in Sickle Cell Disease: Significance And Management
Caboot, J. B., & Allen, J. L. (2013) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2013.12.004 · Cited by 61
Left Ventricular Systolic Function in Sickle Cell Anemia: A Meta-Analysis
Poludasu, S., Ramkissoon, K., Salciccioli, L. F., Kamran, H., & Lazar, J. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.03.009 · Cited by 51
Klings, E. S., Anton Bland, D., Rosenman, D., Princeton, S., Odhiambo, A., Li, G., Bernard, S. A., Steinberg, M. H., & Farber, H. W. (2008) · American Journal of Hematology · doi:10.1002/ajh.21187 · Cited by 51
How I treat the older adult with sickle cell disease
Thein, S. L., & Howard, J. (2018) · Blood · doi:10.1182/blood-2018-03-818161 · Cited by 57
Cardiovascular manifestations of sickle cell disease
Hammoudi, N., Lionnet, F., Redheuil, A. B., & Montalescot, G. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz217 · Cited by 57
Sandrim, V. C., Montenegro, M. F., Palei, A. C., Metzger, I. F., Sertorio, J. T. C., Cavalli, R. D. C., & Tanus-Santos, J. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.05.012 · Cited by 56
Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases
Signori, D., Magliocca, A., Hayashida, K., Graw, J. A., Malhotra, R. K., Bellani, G., Berra, L. M., & Rezoagli, E. (2022) · Intensive Care Medicine Experimental · doi:10.1186/s40635-022-00455-6 · Cited by 62
Rusanova, I., Escames, G., Cossio, G., Borace, R. G. D., Moreno, B., Chahboune, M., López, L. C., Diez, T. A., & Acuña-Castroviejo, D. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01528.x · Cited by 56
Increased Pulmonary Pressures and Myocardial Wall Stress in Children with Severe Malaria
Janka, J., Koita, O., Traoré, B., Traoré, J. M., Mzayek, F., Sachdev, V., Wang, X., Sanogo, K. M., Sangaré, L., Mendelsohn, L. G., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/655225 · Cited by 50
Self-citationEndothelial Function in Patients with Sickle Cell Anemia During and After Sickle Cell Crises
Blum, A., Yeganeh, S., Peleg, A., Vigder, F., Kryuger, K., Khatib, A., Khazim, K., & Dauerman, H. L. (2005) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-005-1377-7 · Cited by 50
Recommandations pratiques de prise en charge de la drépanocytose de l’adulte
Lionnet, F., Arlet, J. B., Bartolucci, P., Habibi, A., Ribeil, J., & Stankovic, K. (2009) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.07.001 · Cited by 49
Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease.
Raman, S. V., Simonetti, O. P., Cataland, S. R., & Kraut, E. H. (2006) · PubMed · Cited by 49
van Beers, E. J., van der Plas, M. N., Nur, E., Bogaard, H. J., van Steenwijk, R. P., Biemond, B. J., & Bresser, P. (2014) · American Journal of Hematology · doi:10.1002/ajh.23752 · Cited by 51
Ranque, B., Menet, A., Boutouyrie, P., Diop, I. B., Kingué, S., Diarra, M., N’Guetta, R., Diallo, D. A., Diop, S., Diagne, I., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.021015 · Cited by 53
Shah, N., Bhor, M., Xie, L., Arcona, S., Halloway, R., Paulose, J., & Yüce, H. (2019) · Journal of health economics and outcomes research · doi:10.36469/9667 · Cited by 51
Increased Pulmonary Artery Pressures Among Adolescents With Sickle Cell Disease
Suell, M. N., Bezold, L. I., Okcu, M. F., Mahoney, D. H., Shardonofsky, F. R., & Mueller, B. U. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000194022.17968.bf · Cited by 49
Update in Pulmonary Arterial Hypertension 2007
Humbert, M. J. C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-029up · Cited by 57
High Prevalence of Pulmonary Hypertension in Children With Sickle Cell Disease
Nelson, S. C., Adade, B. B., McDonough, E. A., Moquist, K. L., & Hennessy, J. M. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31805d8f32 · Cited by 51
IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias
Gupta, A., Fei, Y., Kim, T. Y., Xie, A., Batai, K., Greener, I. D., Tang, H., Ciftci-Yilmaz, S., Juneman, E. B., Indik, J. H., et al. (2020) · Blood · doi:10.1182/blood.2020005944 · Cited by 52
Leveziel, N., Bastuji‐Garin, S., Lalloum, F., Querques, G., Benlian, P., Binaghi, M., COSCAS, G. J., Soubrane, G., Bachir, D., Galactéros, F., et al. (2011) · Medicine · doi:10.1097/md.0b013e3182364cba · Cited by 57
Horwitz, M. E., Spasojević, I., Morris, A., Telen, M. J., Essell, J. H., Gasparetto, C., Sullivan, K. M., Long, G. D., Chute, J. P., Chao, N. J. A., et al. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.08.050 · Cited by 47
2015 Clinical trials update in sickle cell anemia
Archer, N. M., Galactéros, F., & Brugnara, C. (2015) · American Journal of Hematology · doi:10.1002/ajh.24116 · Cited by 58
Respiratory Noises: How Useful are They Clinically?
Mellis, C. (2009) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2008.10.003 · Cited by 51
Stallworth, J. R., Jerrell, J. M., & Tripathi, A. (2010) · American Journal of Hematology · doi:10.1002/ajh.21772 · Cited by 49
Advances in clinical research in sickle cell disease
Hagar, W., & Vichinsky, E. P. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07097.x · Cited by 55
Pulmonary Hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases
Austin, E. D., Kawut, S. M., Gladwin, M. T., & Abman, S. H. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-443ld · Cited by 45
Self-citationDiagnosis of Pulmonary Arterial Hypertension
Forfia, P. R., & Trow, T. K. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.09.001 · Cited by 50
Opportunities to improve outcomes in sickle cell disease.
Mehta, S. R., Afenyi‐Annan, A., Byrns, P. J., & Lottenberg, R. (2006) · PubMed · Cited by 56
Wang, X., Mendelsohn, L., Rogers, H., Leitman, S., Raghavachari, N., Yang, Y., Yau, Y. Y., Tallack, M., Perkins, A., Taylor, J. G., et al. (2014) · Blood · doi:10.1182/blood-2013-11-539718 · Cited by 45
Hemoglobinopathies and sleep – The road less traveled
Gileles‐Hillel, A., Gozal, D., & Gozal, D. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.01.002 · Cited by 48
Nitric oxide pathology and therapeutics in sickle cell disease
Kim‐Shapiro, D. B., & Gladwin, M. T. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189009 · Cited by 55
Self-citationOlnes, M., Chi, A., Haney, C., May, R., Minniti, C., Taylor, J., & Kato, G. J. (2009) · American Journal of Hematology · doi:10.1002/ajh.21446 · Cited by 45
Defining stroke risk in children with sickle cell anaemia
Hoppe, C. C. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05310.x · Cited by 51
Morris, C. R. (2006) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200605010-00003 · Cited by 50
Pulmonary Hypertension Associated with Chronic Hemolytic Anemia and Other Blood Disorders
Machado, R. F., & Farber, H. W. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.006 · Cited by 47
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension
Morris, C. R., Kim, H.-Y., Wood, J. C., Porter, J. B., Klings, E. S., Trachtenberg, F. L., Sweeters, N., Olivieri, N. F., Kwiatkowski, J. L., Virzi, L., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.082065 · Cited by 44
Self-citationPatel, N. N., Gonsalves, C. S., Yang, M., Malik, P., & Kalra, V. K. (2008) · Blood · doi:10.1182/blood-2008-07-169821 · Cited by 43
Eddine, A. C., Alvarez, O. A., Lipshultz, S. E., Kardon, R. E., Arheart, K. L., & Swaminathan, S. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.01.001 · Cited by 43
Pulmonary function, CT and echocardiographic abnormalities in sickle cell disease
Lunt, A. C., Desai, S. R., Wells, A. U., Hansell, D. M., Mushemi-Blake, S., Melikian, N., Shah, A. M., Thein, S. L., & Greenough, A. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204809 · Cited by 47
Tuijn, C. F. J. V., van Beers, E. J., Schnog, J. B., & Biemond, B. J. (2010) · American Journal of Hematology · doi:10.1002/ajh.21731 · Cited by 49
Sickle cell disease: progress towards combination drug therapy
Pace, B. S., Starlard‐Davenport, A., & Kutlar, A. (2021) · British Journal of Haematology · doi:10.1111/bjh.17312 · Cited by 57
Liem, R. I., Nevin, M., Prestridge, A. L., Young, L., & Thompson, A. A. (2009) · American Journal of Hematology · doi:10.1002/ajh.21507 · Cited by 43
van Beers, E. J., Tuijn, C. F. J. V., Gillavry, M. R. M., van der Giessen, A., Schnog, J. B., Biemond, B. J., & on behalf of the CURAMA study group (2008) · Haematologica · doi:10.3324/haematol.12152 · Cited by 49
Ephraim, R. K. D., Osakunor, D. N. M., Cudjoe, O., Oduro, E. A., Asante-Asamani, L., Mitchell, J., Agbodzakey, H., & Adoba, P. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0072-y · Cited by 40
Pack-Mabien, A. V., & Haynes, J. (2009) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2009.00401.x · Cited by 46
Vascular risk assessment in patients with sickle cell disease
Morris, C. R. (2010) · Haematologica · doi:10.3324/haematol.2010.035097 · Cited by 49
Metadata
- Authors
- Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., Hunter, L. A., Blackwelder, W. C., Schechter, A. N., Rodgers, G. P., Castro, O., & Ognibene, F. P.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-26
- Volume
- 350
- Issue
- 9
- Pages
- 886-895
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148547093
- Cited by
- 1,325
- References
- 42
- Citations by year
- 2026: 42 · 2025: 30 · 2024: 45 · 2023: 44 · 2022: 42 · 2021: 47 · 2020: 34 · 2019: 61 · 2018: 43 · 2017: 57 · 2016: 74 · 2015: 64 · 2014: 76 · 2013: 64 · 2012: 68
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- pulmonary hypertension, sickle cell disease, mortality risk, tricuspid regurgitation velocity, Doppler echocardiography, chronic hemolysis, hydroxyurea therapy, risk factors, alkaline phosphatase, lactate dehydrogenase, transferrin, cardiovascular complications, renal complications
- MeSH terms
- Adult, Anemia, Sickle Cell, Antisickling Agents, Blood Pressure, Cause of Death, Drug Resistance, Female, Hemolysis, Humans, Hydroxyurea, Hypertension, Pulmonary, Male, Pulmonary Artery, Risk Factors, Tricuspid Valve Insufficiency, Echocardiography, Doppler, Prevalence, Survival Rate, Logistic Models, Ventricular Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.